| Sanofi-Aventis (Suisse) SA - Apidra, solution injectable |
| 57013 | | 01 | | Apidra | | solution injectable | | A10AB06 | | Insulin glulisine | | 02.05.2005 | | |
|
| Composition |
| insulinum glulisinum 3.49 mg corresp. insulinum glulisinum 100 U., metacresolum, trometamolum, natrii chloridum, polysorbatum 20, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabilia q.s. ad solutionem pro 1 ml corresp. natrium 1.97 mg. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Insuline Glulisine | 3.49 mg/ml correspond Insuline Glulisine 100 U/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Insuline Glulisine | 100 U |
| | | | Agents auxilliaires |
|---|
| Acidum Hydrochloridum | | Metacresol | | Sodium Chlorure | | Sodium Hydroxide | | Polysorbatum 20 | | Trometamol |
| |
|
|
